Methotrexate's Impact on Neutrophils: Insights for Metabolic Health

Rheumatoid arthritis (RA) is a chronic inflammatory condition characterized by joint inflammation and oxidative stress, significantly impacting metabolic health. Neutrophils, a type of immune cell, play a crucial role in this process, often transdifferentiating into 'neutrophil-dendritic cell hybrids' (N-DCs) that exhibit enhanced oxidative stress and antigen-presenting capabilities. This study investigates the effects of methotrexate (MTX), a standard treatment for RA, on neutrophil function and bioenergetics, particularly under oxidative stress conditions induced by phorbol 12-myristate 13-acetate (PMA). The research found that MTX did not alter the generation of reactive oxygen species (ROS) in neutrophils under normal conditions. However, when oxidative stress was induced by PMA, MTX significantly enhanced ROS generation and increased the percentage of activated neutrophils (CD83^high/HLA-DR^high). Additionally, MTX raised levels of myeloperoxidase, an enzyme associated with neutrophil activation, and elevated apoptotic markers such as Annexin V and Caspase 3, while downregulating Bcl-2, a protein that inhibits apoptosis. Notably, MTX did not change the oxygen consumption rate (OCR) of neutrophils, but under PMA-induced oxidative stress, it increased OCR, indicating altered bioenergetic status without affecting glycolytic pathways. These findings suggest that while MTX is effective in treating RA, it may have adverse effects on neutrophil behavior in oxidative stress conditions, potentially complicating the inflammatory response. For individuals managing RA or similar inflammatory conditions, understanding the dual role of MTX in promoting neutrophil activation while not directly altering oxidative stress levels is crucial. This knowledge can guide treatment decisions and lifestyle interventions aimed at managing oxidative stress and inflammation. For those interested in monitoring their metabolic health, this research connects to several biomarkers. Elevated levels of oxidative stress can be assessed through inflammation markers like hsCRP, while neutrophil activity may indirectly influence lipid metabolism and insulin sensitivity. Regular monitoring of these biomarkers can provide insights into the effectiveness of dietary interventions, such as low-carb or ketogenic diets, which may help mitigate inflammation and improve metabolic health. In conclusion, while methotrexate remains a cornerstone in RA treatment, its complex effects on neutrophil function highlight the importance of personalized approaches in managing metabolic health. Patients should consult healthcare providers to tailor their treatment and lifestyle strategies, considering the potential oxidative stress implications of their therapies.